Today, on
Q3 2023 KEY INDICATORS
- Net sales amounted to 36.3 MSEK (34.1)
- EBITDA equalled 4.8 MSEK (4.8)
- Operating profit (EBIT) is 1.5 MSEK (1.4)
- Profit after tax amounted to 0.5 MSEK (1.2)
- Earnings per share
SEK 0,1 (0,1) per share
JAN-
- Net sales amounted to 113.1 MSEK (99.8)
- EBITDA equalled 21.8 MSEK (20.1)
- Operating profit (EBIT) is 12.1 MSEK (10.1)
- Profit after tax amounted to 8.1 MSEK (9.1)
- Earnings per share
SEK 0,8 (0,8) per share
“Magle Group has made yet another strong quarter, both in terms of revenue and profit. Total revenues from our CDMO business and DSM-based products increased by 6.7% percent compared to last year’s corresponding period, which is well within our expectations. During the quarter, we have taken a major step in our commercialization strategy by signing a worldwide distribution agreement with the global medical device company, Sirtex Medical” says
The full report is available at https://maglegroup.com/financial-reports/
© Modular Finance, source